Iovance Biotherapeutics

Iovance Biotherapeutics

IOVA· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock -63.1% in FY2025

Frederick G. Vogt, Ph.D., J.D. is the CEO of Iovance Biotherapeutics and was paid $1.9M in FY2025 (Dec), down 83%.

Pay$100 in the stock at the end of FY20 → $6
CEO pay is from each Iovance Biotherapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives7

See all
  1. 1Daniel KirbyFY2025
  2. 2Frederick G. Vogt, Ph.D., J.D.FY2025
  3. 3Corleen RocheFY2025
  4. 4Raj K. Puri, M.D., Ph.D.FY2025
  5. 5Igor Bilinsky, Ph.D.FY2025
  6. 6Matthew W. RosinackFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Iovance Biotherapeutics paid its 7 named executives $9.4M in total in FY2025 (Dec). CEO Frederick G. Vogt, Ph.D., J.D. was paid $1.9M of that.

Name
Daniel KirbyChief Commercial OfficerNot disclosedNot disclosed
Frederick G. Vogt, Ph.D., J.D.Interim Chief Executive Officer and President, General Counsel
Corleen RocheChief Financial OfficerNot disclosedNot disclosed
Raj K. Puri, M.D., Ph.D.Chief Regulatory OfficerNot disclosed
Igor Bilinsky, Ph.D.Chief Operating Officer
Matthew W. RosinackInterim Principal Financial Officer and Principal Accounting OfficerNot disclosedNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers16

See all

The FY2025 (Dec) proxy of Iovance Biotherapeutics names 16 peer companies for pay. Pay versus performance data of Iovance Biotherapeutics for that year is not on file, so it has no rank.

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board2

See all
  • Wayne P. RothbaumDirector · 9 yr on the boardIndependentCompensation—Paid as an executive
  • Athena CountouriotisDirector · 6 yr on the boardIndependentCompensation—Paid as an executive

The board of the latest proxy (FY2025).

Activity

  1. PayDEF 14A
  2. PayDEF 14A
  3. PayDEF 14A
  4. PayDEF 14A
  5. PayDEF 14A
  6. PayDEF 14A
  7. PayDEF 14A
  8. PayDEF 14A
  9. PayDEF 14A
  10. PayDEF 14A
  11. PayDEF 14A
  12. PayDEF 14A
  13. PayDEF 14A
  14. PayDEF 14A
  15. PayDEF 14A

Filings6

See all
Proxy statementDEF 14AApr 28, 2026FY2025
Annual report10-KFeb 24, 2026FY2025
Proxy statementDEF 14AApr 28, 2025FY2024
Annual report10-KFeb 27, 2025FY2024
Proxy statementDEF 14AApr 29, 2024FY2023
Annual report10-KFeb 28, 2024FY2023